China Pharma Holdings Stock Math Transform Inverse Tangent Over Price Movement

CPHI Stock  USD 0.20  0.01  5.26%   
China Pharma math transform tool provides the execution environment for running the Inverse Tangent Over Price Movement transformation and other technical functions against China Pharma. China Pharma value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of math transform indicators. As with most other technical indicators, the Inverse Tangent Over Price Movement transformation function is designed to identify and follow existing trends. Analysts that use price transformation techniques rely on the belief that biggest profits from investing in China Pharma can be made when China Pharma shifts in price trends from positive to negative or vice versa.

Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. China Pharma Holdings Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe China Pharma price patterns.

China Pharma Technical Analysis Modules

Most technical analysis of China Pharma help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for China from various momentum indicators to cycle indicators. When you analyze China charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About China Pharma Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of China Pharma Holdings. We use our internally-developed statistical techniques to arrive at the intrinsic value of China Pharma Holdings based on widely used predictive technical indicators. In general, we focus on analyzing China Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build China Pharma's daily price indicators and compare them against related drivers, such as math transform and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of China Pharma's intrinsic value. In addition to deriving basic predictive indicators for China Pharma, we also check how macroeconomic factors affect China Pharma price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2023 2024 (projected)
Dividend Yield0.0021050.00187
Price To Sales Ratio0.290.28
Hype
Prediction
LowEstimatedHigh
0.010.207.24
Details
Intrinsic
Valuation
LowRealHigh
0.010.187.22
Details
Naive
Forecast
LowNextHigh
00.197.22
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.160.210.25
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as China Pharma. Your research has to be compared to or analyzed against China Pharma's peers to derive any actionable benefits. When done correctly, China Pharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in China Pharma Holdings.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards China Pharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, China Pharma's short interest history, or implied volatility extrapolated from China Pharma options trading.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Momentum Idea
Momentum
Invested over 200 shares
Cash Cows Idea
Cash Cows
Invested few shares
Hedge Favorites Idea
Hedge Favorites
Invested few shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Power Assets Idea
Power Assets
Invested over 200 shares
Baby Boomer Prospects Idea
Baby Boomer Prospects
Invested over 40 shares
Dividend Beast Idea
Dividend Beast
Invested over 50 shares
Electronic Equipment Idea
Electronic Equipment
Invested few shares
Housewares Idea
Housewares
Invested few shares
Defense Idea
Defense
Sold few shares
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares
Chemicals Idea
Chemicals
Invested over 30 shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested few shares
When determining whether China Pharma Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of China Pharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of China Pharma Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on China Pharma Holdings Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in China Pharma Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of China Pharma. If investors know China will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about China Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.69)
Revenue Per Share
0.63
Quarterly Revenue Growth
(0.16)
Return On Assets
(0.18)
Return On Equity
(0.75)
The market value of China Pharma Holdings is measured differently than its book value, which is the value of China that is recorded on the company's balance sheet. Investors also form their own opinion of China Pharma's value that differs from its market value or its book value, called intrinsic value, which is China Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because China Pharma's market value can be influenced by many factors that don't directly affect China Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between China Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if China Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, China Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.